首页> 外国专利> A process for the preparation of therapeutically useful benzylg / indole-2,3-dione-3-hydrazone derivatives and 6,7,8,9-tetrahydrobenzylgindole-2,3-dione hydrazone derivatives

A process for the preparation of therapeutically useful benzylg / indole-2,3-dione-3-hydrazone derivatives and 6,7,8,9-tetrahydrobenzylgindole-2,3-dione hydrazone derivatives

机译:一种制备治疗上有用的苄基/吲哚-2,3-二酮-3-hydr衍生物和6,7,8,9-四氢苄基金吲哚-2,3-二酮衍生物的方法

摘要

A method of treatment with compounds having the formula CHEM wherein n is 0 or 1; R1 is hydrogen, C1-6-alkyl which may be branched, C3-7-cycloalkyl, benzyl, phenyl which may be substituted, acyl, hydroxy, C1-6-alkoxy, CH2CO2R' wherein R' is hydrogen or C1-6-alkyl which may be branched, CH2CN, CH2CONRIVRV wherein RIV and RV independently are hydrogen or C1-6-alkyl, or CH2C(=NOH)NH2; R2 is pyridyl or phenyl, both of which may be substituted one or more times preferably in the ortho and para positions with halogen, CF3, NO2, CN, phenyl, SO2NR''R''' wherein R'' and R''' independently are hydrogen, benzyl, or C1-6-alkyl; R4, R5, R6, R7 independently are hydrogen, C1-6-alkyl which may be branched, phenyl, halogen, C1-6-alkoxy, NO2, CN, CF3, or SO2NR11R12 wherein R11 and R12 independently are hydrogen, benzyl, or C1-6-alkyl; or R6 and R7 together form an additional 4 to 8 membered carbocyclic ring which may be aromatic or partial saturated and which may be substituted with halogen, NO2, CF3, CN, SO2NR13R14 wherein R13 and R14 independently are hydrogen, benzyl, or C1-6-alkyl, and R4 and R5 have the meanings set forth above; or R4 and R5 together form an additional 4 to 8 membered carbocyclic ring which may be aromatic or partial saturated and which may be substituted with halogen, NO2, CF3, CN, SO2NR13R14 wherein R13 and R14 independently are hydrogen, benzyl, or C1-6-alkyl, and R6 and R7 have the meanings set forth above. Certain of the compounds are novel. The compounds and pharmaceutical compositions containing the compounds are useful in the treatment of central nervous system disorders and especially conditions sensitive to excitatory amino acids.
机译:一种具有化学式的化合物的处理方法,其中n为0或1; R 1是氢,可分支的C 1-6-烷基,C 3-7-环烷基,苄基,可被取代的苯基,酰基,羟基,C 1-6-烷氧基,CH 2 CO 2 R',其中R'是氢或C1可为支链的-6-烷基,CH 2 CN,CH 2 CONR IV,其中R IV和R V独立地为氢或C 1-6烷基,或CH 2 C(= NOH)NH 2; R 2是吡啶基或苯基,两者均可优选在邻位和对位被卤素,CF 3,NO 2,CN,苯基,SO 2 NR'R'''(其中R''和R)取代一次或多次。 '''独立地是氢,苄基或C 1-6-烷基; R 4,R 5,R 6,R 7独立地为氢,可分支的C 1-6烷基,苯基,卤素,C 1-6烷氧基,NO 2,CN,CF 3或SO 2 NR 1 1 R 1 2,其中R 1 1和R 1 2独立地是氢,苄基或C 1-6-烷基;或R 6和R 7一起形成另外的4至8元碳环,其可以是芳香族的或部分饱和的,并且可以被卤素,NO 2,CF 3,CN,SO 2 NR 1 3取代。 1 4,其中R 1 3和R 1 4独立地为氢,苄基或C 1-6-烷基,并且R 4和R 5具有上述含义;或R 4和R 5一起形成另外的4至8元碳环,其可以是芳族的或部分饱和的并且可以被卤素,NO 2,CF 3,CN,SO 2 NR 1 3取代。 1 4,其中R 1 3和R 1 4独立地是氢,苄基或C 1-6-烷基,并且R 6和R 7具有上述含义。某些化合物是新颖的。所述化合物和包含所述化合物的药物组合物可用于治疗中枢神经系统疾病,尤其是对兴奋性氨基酸敏感的疾病。

著录项

  • 公开/公告号FI103276B

    专利类型

  • 公开/公告日1999-05-31

    原文格式PDF

  • 申请/专利权人 NEUROSEARCH A/S;

    申请/专利号FI19920001049

  • 发明设计人 DAHLBJARNE HUGO;WAETJENFRANK;

    申请日1992-03-11

  • 分类号C07D209/40;A61K31/40;

  • 国家 FI

  • 入库时间 2022-08-22 02:27:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号